Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid

International Journal of Developmental Neuroscience

Volumn 26, Issue 7, 2008, Pages 665-671

  Pelegrí, Carme ^a,c   Duran Vilaregut, Joaquim ^a,c   del Valle, Jaume ^a,c   Crespo Biel, Natàlia ^a,c   Ferrer, Isidre ^b,c   Pallàs, Mercè ^a,c   Camins, Antoni ^a,c   Vilaplana, Jordi ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Apoptosis; Cell cycle; Huntington's disease; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; CYCLIN D1; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CONTROLLED STUDY; CORPUS STRIATUM; GENETIC ASSOCIATION; HUMAN; HUNTINGTON CHOREA; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT REDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CONVULSANTS; CORPUS STRIATUM; CYCLIN D1; DISEASE MODELS, ANIMAL; DYSKINESIA, DRUG-INDUCED; E2F1 TRANSCRIPTION FACTOR; FEMALE; G1 PHASE; GENE EXPRESSION REGULATION; GENES, CDC; HUMANS; HUNTINGTON DISEASE; MALE; NERVE DEGENERATION; NEURONS; NEUROTOXINS; NITRO COMPOUNDS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

RATTUS;

EID: 53049106429     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2008.07.016     Document Type: Article

References (45)

1. Akashiba H., Ikegaya Y., Nishiyama N., and Matsuki N. Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid. J. Biol. Chem. 283 (2008) 6594-6606
2. Bizat N., Hermel J.M., Boyer F., Jacquard C., Créminon C., Ouary S., Escartin C., Hantraye P., Kajewski S., and Brouillet E. Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. J. Neurosci. 23 (2003) 5020-5030 (Erratum in J. Neurosci. 23 (2003) 9960)
3. Brouillet E., Guyot M.C., Mittoux V., Altairac S., Condé F., Palfi S., and Hantraye P. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J. Neurochem. 70 (1998) 794-805
4. Brouillet E., Jacquard C., Bizat N., and Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J. Neurochem. 95 (2005) 1521-1540
5. Camins A., Verdaguer E., Folch J., and Pallàs M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev. 12 (2006) 135-148
6. Camins A., Verdaguer E., Folch J., Beas-Zárate C., Canudas A.M., and Pallàs M. Inhibition of ataxia telangiectasia-p53-E2F-1 pathway in neurons as a target for the prevention of neuronal apoptosis. Curr. Drug Metab. 8 (2007) 709-715
7. Camins A., Pallas M., and Silvestre J.S. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Find. Exp. Clin. Pharmacol. 30 (2008) 43-65
8. Crespo-Biel N., Camins A., Pelegrí C., Vilaplana J., Pallàs M., and Canudas A.M. 3-Nitropropionic acid activates calpain/cdk5 pathway in rat striatum. Neurosci. Lett. 421 (2007) 77-81
9. Gendron T.F., Mealing G.A., Paris J., Lou A., Edwards A., Hou S.T., MacManus J.P., Hakim A.M., and Morley P. Attenuation of neurotoxicity in cortical cultures and hippocampal slices from E2F-1 knockout mice. J. Neurochem. 78 (2001) 316-324
10. Giovanni A., Wirtz-Brugger F., Keramaris E., Slack R., and Park D.S. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F × DP, in B-amyloid-induced neuronal death. J. Biol. Chem. 274 (1999) 19011-19016
11. Giovanni A., Keramaris E., Morris E.J., Hou S.T., O'Hare M., Dyson N., Robertson G.S., Slack R.S., and Park D.S. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 275 (2000) 11553-11560
12. Höglinger G.U., Breunig J.J., Depboylu C., Rouaux C., Michel P.P., Alvarez-Fischer D., Boutillier A.L., Degregori J., Oertel W.H., Rakic P., Hirsch E.C., and Hunot S. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 3585-3590
13. Hou S.T., Cowan E., Dostanic S., Rasquinha I., Comas T., Morley P., and MacManus J.P. Increased expression of the transcription factor E2F1 during dopamine-evoked, caspase-3-mediated apoptosis in rat cortical neurons. Neurosci. Lett. 306 (2001) 153-156
14. Hou S.T., Cowan E., Walker T., Ohan N., Dove M., Rasqinha I., and MacManus J.P. The transcription factor E2F-1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation. J. Neurochem. 78 (2001) 287-297
15. Iqbal K., and Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J. Cell. Mol. Med. 12 (2008) 38-55
16. Jordan-Sciutto K.L., Dorsey R., Chalovich E.M., Hammond R.R., and Achim C.L. Expression patterns of retinoblastoma protein in Parkinson disease. J. Neuropathol. Exp. Neurol. 62 (2003) 68-74
17. Konishi Y., and Bonni A. The E2F-Cdc2 cell-cycle pathway specifically mediates activity deprivation-induced apoptosis of postmitotic neurons. J. Neurosci. 23 (2003) 1649-1658
18. Kranenburg O., van der Eb A.J., and Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J. 15 (1996) 46-54
19. Krantic S., Mechawar N., Reix S., and Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci. 28 (2005) 670-676
20. Liu D.X., and Greene L.A. Regulation of neuronal survival and death by E2F-dependent gene repression and derepression. Neuron 32 (2001) 425-438
21. MacManus J.P., Jian M., Preston E., Rasquinha I., Webster J., and Zurakowski B. Absence of the transcription factor E2F-1 attenuates brain injury and improves behavior after focal ischemia in mice. J. Cereb. Blood Flow Metab. 23 (2003) 1020-1028
22. Majd S., Zarifkar A., Rastegar K., and Takhshid M.A. Different fibrillar Abeta 1-42 concentrations induce adult hippocampal neurons to reenter various phases of the cell cycle. Brain Res. 1218 (2008) 224-229
23. Manfredi G., and Beal M.F. Merging mitochondria for neuronal survival. Nat. Med. 13 (2007) 1140-1141
24. Motonaga K., Itoh M., Hirayama A., Hirano S., Becker L.E., Goto Y., and Takashima S. Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia. Brain Res. 905 (2001) 250-253
25. Nguyen M.D., Boudreau M., Kriz J., Couillard-Després S., Kaplan D.R., and Julien J.P. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J. Neurosci. 23 (2003) 2131-2140
26. Nunomura A., Moreira P.I., Lee H.G., Zhu X., Castellani R.J., Smith M.A., and Perry G. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol. Disord. Drug Targets 6 (2007) 411-423
27. O'Hare M.J., Hou S.T., Morris E.J., Cregan S.P., Xu Q., Slack R.S., and Park D.S. Induction and modulation of cerebellar granule neuron death by E2F-1. J. Biol. Chem. 275 (2000) 25358-25364
28. Pallàs M., and Camins A. Molecular and biochemical features in Alzheimer's disease. Curr. Pharm. Des. 12 (2006) 4389-4408
29. Pang Z., Bondada V., Sengoku T., Siman R., and Geddes J.W. Calpain facilitates the neuron death induced by 3-nitropropionic acid and contributes to the necrotic morphology. J. Neuropathol. Exp. Neurol. 62 (2003) 633-643
30. Park D.S., Morris E.J., Bremner R., Keramaris E., Padmanabhan J., Rosenbaum M., Shelanski M.L., Geller H.M., and Greene L.A. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage. J. Neurosci. 20 (2000) 3104-3114
31. Pelegrí C., Canudas A.M., del Valle J., Casadesus G., Smith M., Camins A., Pallàs M., and Vilaplana J. Increased permeability of blood-brain barrier on the hippocampus of a murine model of senescence. Mech. Ageing Dev. 128 (2007) 522-528
32. Phillips A.C., Ernst M.K., Bates S., Rice N.R., and Vousden K.H. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell. 4 (1999) 771-781
33. Przedborski S., Tieu K., Perier C., and Vila M. MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J. Bioenergy Biomembr. 36 (2004) 375-379
34. Ranganathan S., and Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol. 162 (2003) 823-835
35. Smith R.A., Walker T., Xie X., and Hou S.T. Involvement of the transcription factor E2F-1/Rb in kainic acid-induced death of murine cerebellar granule cells. Mol. Brain Res. 116 (2003) 70-79
36. Stanelle J., and Pützer B.M. E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol. Med. 12 (2006) 177-185
37. Strachan G.D., Koike M.A., Siman R., Hall D.J., and Jordan-Sciutto K.L. E2F-1 induces cell death, calpain activation, and MDMX degradation in a transcription independent manner implicating a novel role for E2F-1 in neuronal loss in SIV encephalitis. J. Cell Biochem. 96 (2005) 728-740
38. Stuss D.T., and Levine B. The dementias: nosological and clinical factors related to diagnosis. Brain Cogn. 31 (1996) 99-113
39. Verdaguer E., Jordà E.G., Canudas A.M., Jiménez A., Sureda F.X., Rimbau V., Pubill D., Escubedo E., Camarasa J., Pallàs M., and Camins A. 3-Amino thioacridone, a selective cyclin-dependent kinase 4 inhibitor, attenuates kainic acid-induced apoptosis in neurons. Neuroscience 120 (2003) 599-603
40. Verdaguer E., Jiménez A., Canudas A.M., Jordà E.G., Sureda F.X., Pallàs M., and Camins A. Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment. J. Pharmacol. Exp. Ther. 308 (2004) 609-616
41. Vila M., and Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 4 (2003) 365-375
42. Woods J., Snape M., and Smith M.A. The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. Biochim. Biophys. Acta 1772 (2007) 503-508
43. Yeste-Velasco M., Folch J., Trullàs R., Abad M.A., Enguita M., Pallàs M., and Camins A. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells. Neuropharmacology 53 (2007) 295-307
44. Zhang M., Li J., Chakrabarty P., Bu B., and Vincent I. Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice. Am. J. Pathol. 165 (2004) 843-853
45. Zhu X., Lee H.G., Perry G., and Smith M.A. Alzheimer disease, the two-hit hypothesis: an update. Biochim. Biophys. Acta 1772 (2007) 494-502